Results 191 to 200 of about 22,675 (238)

Clinical Phenotype Transition in Pemphigus May Suggest Undertreatment with Rituximab: Findings from a Retrospective Single-Centre Analysis of Relapsed Patients.

open access: yesDermatology
Strandmoe AL   +10 more
europepmc   +1 more source

The Role of Genetic Testing in the Differential Diagnosis of Pustular Dermatoses: A Pediatric Case of Generalized Pustular Psoriasis Associated with the IL36RN Variant. [PDF]

open access: yesJ Clin Med
Markwitz M   +10 more
europepmc   +1 more source

Pemphigus

Lancet, The, 2019
Pemphigus consists of a group of rare and severe autoimmune blistering diseases mediated by pathogenic autoantibodies mainly directed against two desmosomal adhesion proteins, desmoglein (Dsg)1 and Dsg3 (also known as DG1 and DG3), which are present in the skin and surface-close mucosae.
Enno Schmidt   +2 more
exaly   +5 more sources

Pemphigus

Dental Clinics of North America, 2005
Pemphigus is an umbrella term for more than 10 different epidermal disease types and subtypes currently classified under this name. Characteristic for pemphigus are the presence of autoantibodies against epidermal cell adhesion structures (desmosomes), leading to a breakdown of cutaneous and mucosal barriers.
Jean-Claude, Bystryn   +1 more
openaire   +4 more sources

Pemphigus

Journal of the European Academy of Dermatology and Venereology, 2008
AbstractPemphigus refers to a group of potentially life‐threatening autoimmune diseases of the skin and mucous membranes, characterized by the formation of blisters and erosions of the skin. An autoimmune process, directed against keratinocyte desmosomal cadherins, interferes with the adhesive function of these molecules. This results in the separation
D, Ioannides   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy